These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21148125)

  • 21. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mexican flu: risk perception in the general public, precautionary measures and trust in information provided by the government].
    Bults M; Beaujean DJ; de Zwart O; Kok G; van Empelen P; van Steenbergen JE; Richardus JH; Voeten HA
    Ned Tijdschr Geneeskd; 2010; 154():A1686. PubMed ID: 20482914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines for the prevention of diseases caused by potential bioweapons.
    Hassani M; Patel MC; Pirofski LA
    Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating vaccine-preventable disease surveillance into the National Health Information Network: leveraging children's hospitals.
    Fine AM; Goldmann DA; Forbes PW; Harris SK; Mandl KD
    Pediatrics; 2006 Oct; 118(4):1431-8. PubMed ID: 17015533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential global market size and public health value of an HIV-1 vaccine in a complex global market.
    Marzetta CA; Lee SS; Wrobel SJ; Singh KJ; Russell N; Esparza J
    Vaccine; 2010 Jul; 28(30):4786-97. PubMed ID: 20471439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic vaccines: a solution to the prevention problem?
    Dawson A
    Vaccine; 2005 Mar; 23(17-18):2363-6. PubMed ID: 15755629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protecting public trust in immunization.
    Cooper LZ; Larson HJ; Katz SL
    Pediatrics; 2008 Jul; 122(1):149-53. PubMed ID: 18595998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A risk-benefit analysis of vaccination.
    Heininger U
    Vaccine; 2009 Dec; 27 Suppl 6():G9-G12. PubMed ID: 20006145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conclusions. The precautionary principle: its advantages and risks].
    Tubiana M
    Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumer attitudes to vaccination of food-producing animals.
    Scudamore JM
    Rev Sci Tech; 2007 Aug; 26(2):451-9. PubMed ID: 17892165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine requirements and priorities for developing countries.
    Thongcharoen P
    J Med Assoc Thai; 1986 Sep; 69(9):505-10. PubMed ID: 3794567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [WHO Influenza Global Agenda].
    Donatelli I; Pregliasco F
    Ann Ist Super Sanita; 2003; 39(3):425-33. PubMed ID: 15098565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine side effects: fact and fiction.
    Day MJ
    Vet Microbiol; 2006 Oct; 117(1):51-8. PubMed ID: 16701964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is vaccine advocacy? Proposal for a definition and action.
    Balinska MA
    Vaccine; 2004 Mar; 22(11-12):1335-42. PubMed ID: 15063555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivering influenza vaccine to pregnant women.
    Naleway AL; Smith WJ; Mullooly JP
    Epidemiol Rev; 2006; 28():47-53. PubMed ID: 16731574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines.
    Larson HJ; Smith DM; Paterson P; Cumming M; Eckersberger E; Freifeld CC; Ghinai I; Jarrett C; Paushter L; Brownstein JS; Madoff LC
    Lancet Infect Dis; 2013 Jul; 13(7):606-13. PubMed ID: 23676442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.